This may be due to the involvement of compensatory mechanisms as reported
for STAT 3 in response to dasatinib in head and neck cancer and mesothelioma. We further display that EBIP forms hetero dimer with EGFR in MDA MB 468 cells resulting in reduced EGFR signaling.
